Navigation Links
FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications
Date:5/29/2008

Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology

Companies

NEW YORK, May 29 /PRNewswire/ -- ExL Pharma (http://www.exlpharma.com) is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical, Biotech and Medical Technology Corporate and Brand Communicators taking place on July 14-15, 2008 at the Heldrich Conference Center in New Brunswick, N.J. (http://www.exlpharma.com/eventDetail.php?id=112) Susan Winckler, Chief of Staff at the FDA will share an update on improving communication issues with the FDA. This presentation is much anticipated as a result of ongoing press on the relationship between the agency and industry. Also confirmed to speak is Peter Thonis, Chief Communications Officer with Verizon. Mr. Thonis is going to lend his insight to the pharmaceutical executives in attendance on communicating with key stakeholders and keeping customers, an area that Verizon has had much success.

The 4th Annual Public Relations and Communications Summit (http://www.exlpharma.com/eventDetail.php?id=112) event brings together communication executives, press and agencies to discuss best practices and challenges relating to corporate, brand and internal communication strategies. Now in its 4th year, this premier event has grown to become the industry standard for senior executives seeking educational and networking opportunities in this field.

Additional program highlights include the number of industry case studies around key issues and challenges that our industry is currently facing. Topics that will be discussed include: new media tools, communicating more effectively with press, internal communications, handling a crisis, the ongoing reputation challenge, DTC advertising, key policy and legislative issues, ROI measurement, corporate social responsibility, agency/client relations, advocacy relations, marketing & PR collaboration, global PR, and much more.

Speakers include senior representatives from many of the leading pharmaceutical, biotech and medical technology companies such as: Abbott, BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer, sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.

This premier event is co-sponsored by DS Simon, Fleishman Hillard, Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.

By attending this event, you will have the rare opportunity to networking with highly regarded communication executives from this industry, leading agency executives and key press/media such as the Wall Street Journal.

To maximize your company's exposure and take advantage of senior-level networking opportunities through sponsorship and exhibiting, please contact: Bryon Main, at bmain@exlpharma.com or by phone at 212-400-6246

To view the full program agenda and full roster of our expert speaking faculty and to REGISTER*
Log onto: http://www.exlpharma.com

* When registering, provide Registration and Priority Code: P218PR1

EARLY REGISTRATION RATES EXPIRE TOMORROW -MAY 30TH- REGISTER NOW AND SAVE

About ExL

ExL Pharma, a division of ExL Events, Inc., is an international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.


'/>"/>
SOURCE ExL Pharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... ... to help the agriculture industry reach its ideal customers with the right message. ... nation. , “As a Midwest company, we realize how crucial the agriculture industry ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... applications in the clinic is here. The team at Capricor Therapeutics, Inc. utilized ... medium for clinical studies. , Dr. Travis Antes, head of analytical development ...
(Date:8/10/2017)... ... August 09, 2017 , ... Okyanos Center for Regenerative Medicine has announced ... Bay Hotel in Freeport, Grand Bahama on September 27, 2017. This daytime event is ... oversight from the Ministry of Health’s National Stem Cell Ethics Committee (NSCEC) and regulations ...
(Date:8/10/2017)... ... August 10, 2017 , ... DrugDev and the Society for ... demonstrate how Good Clinical Practice (GCP) can be used throughout the site activation process ... discuss the importance of GCP compliance, how sites are affected by GCP during selection ...
Breaking Biology Technology:
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):